Tag
Shukra Pharmaceuticals Ltd
2 articles
Shukra Pharmaceuticals Denies Unannounced Price-Sensitive Information
Shukra Pharmaceuticals Ltd. responded to an NSE query regarding a significant recent increase in its share price.
The company confirmed strict adherence to SEBI LODR Regulation 30, promptly disclosing
Shukra Pharmaceuticals Clarifies Price Movement to BSE
Shukra Pharmaceuticals Ltd responds to BSE's query on significant recent share price movement.
Company confirms full compliance with SEBI LODR Regulation 30 and timely disclosure of all material event